Raj Chovatiya, MD, PhD: Takeaways from New Data on Vitiligo, Atopic Dermatitis, HS Treatments

This post-AAD interview with Chovatiya covered takeaways regarding recent data on upadacitinib for vitiligo, tapinarof for eczema, and lutikizumab for hidradenitis suppurativa.

Related Keywords

Chicago ,Illinois ,United States ,San Diego ,California ,American ,Raj Chovatiya ,American Academy Of Dermatology ,Immunology Research ,Rosalind Franklin University Chicago Medical School ,Medical Dermatology ,Upadacitinib ,Vitiligo ,Sad ,Lutikizumab ,Tapinarof ,Eczema ,Hidradenitis Suppurativa ,